ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 1942

$475K Total Retail Price of All Prescriptions

Rank: 126 out of 1942

348 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 506 398 1 1
LEVOTHYROXINE SODIUM 382 319 2 3
OMEPRAZOLE 371 301 3 4
AMLODIPINE BESYLATE 343 288 4 6
METFORMIN HCL 309 208 5 10
METOPROLOL TARTRATE 294 262 6 9
METOPROLOL SUCCINATE 283 254 7 13
LISINOPRIL 282 269 8 2
BENAZEPRIL HCL 278 219 9 158
FUROSEMIDE 265 238 10 5
ATENOLOL 254 214 11 7
HYDROCHLOROTHIAZIDE 218 177 12 8
LOSARTAN POTASSIUM 178 165 13 18
ATORVASTATIN CALCIUM 172 166 14 14
ALENDRONATE SODIUM 170 153 15 21
CITALOPRAM HBR 156 135 16 15
CRESTOR 142 108 17 34
POTASSIUM CHLORIDE 136 102 18 17
PRAVASTATIN SODIUM 130 93 19 23
WARFARIN SODIUM 126 108 20 11
GABAPENTIN 126 98 20 16
TRAZODONE HCL 108 106 22 24
SERTRALINE HCL 99 84 23 20
DONEPEZIL HCL 99 99 23 30
NAMENDA 84 84 25 51
NOVOLOG FLEXPEN 81 60 26 107
DIOVAN 81 56 26 44
TRIAMTERENE-HCTZ 81 71 26 36
ALLOPURINOL 71 58 29 26
RAMIPRIL 67 56 30 111
ZETIA 62 41 31 75
CARVEDILOL 62 50 31 39
AMITRIPTYLINE HCL 62 48 R 31 65
GEMFIBROZIL 62 62 31 60
GLYBURIDE 58 46 R 35 69
DIGOXIN 54 54 36 40
LANTUS 53 46 37 49
CLOPIDOGREL 53 45 37 55
GLIPIZIDE 52 52 39 63
FLUTICASONE PROPIONATE 51 38 40 37
NOVOLOG 50 44 41 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.